2 | Agammaglobulinaemia Tyrosine KinaseIBA
01/2019
-
04/2012 |
2 | Methotrexate (Mexate)FDA LinkGeneric
01/2018
-
04/2012 |
2 | Interleukin-17 (Interleukin 17)IBA
08/2015
-
01/2013 |
1 | Fc Receptors (Fc Receptor)IBA
01/2019 |
1 | fedratinibIBA
01/2019 |
1 | ruxolitinibIBA
01/2019 |
1 | N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
01/2019 |
1 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
01/2019 |
1 | evobrutinibIBA
01/2019 |
1 | Biological ProductsIBA
01/2018 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 |
1 | Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
07/2017 |
1 | Histone Acetyltransferases (Histone Acetyltransferase)IBA
12/2015 |
1 | I-CBP112IBA
12/2015 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
12/2015 |
1 | Monoclonal AntibodiesIBA
08/2015 |
1 | Interleukin-23 (Interleukin 23)IBA
08/2015 |
1 | Thromboplastin (Tissue Factor)IBA
01/2015 |
1 | LipidsIBA
01/2015 |
1 | Phosphotransferases (Kinase)IBA
04/2014 |
1 | AntibodiesIBA
01/2013 |
1 | CytokinesIBA
01/2013 |
1 | Phosphatidylinositols (Phosphatidylinositol)IBA
04/2012 |
1 | RN486IBA
04/2012 |
1 | NF-KappaB Inhibitor alphaIBA
10/2006 |
1 | Proteins (Proteins, Gene)FDA Link
10/2006 |